LifeSciences BC is governed by a Board of Directors, whose members represent British Columbia’s biopharmaceutical, biotechnology, medical devices, digital health and greater life sciences community. Our board provides guidance, sets policy and ensures that the organization operates effectively in achieving its mandate, which is to foster the economic development of B.C.’s life sciences industry.
James P. Hatton Q.C. – Partner, Technology Group, Farris, Vaughan, Wills & Murphy LLP
Nancy Harrison – President, MSI Methylation Sciences Inc.
Gordon McCauley – President & CEO, Centre for Drug Research & Development
Ian Heine – Partner, PwC
Andrew Booth – Chief Financial Officer, STEMCELL Technologies Inc.
Dr. Brendan Byrne – Chief Innovations Officer, TELUS Health
Robin Ciceri – President, The Research Universities’ Council of BC
Doug Janzen – Co-Founder and Managing Director, Northview LifeSciences
Alexei Marko – CEO & Director, Neovasc Inc.
Dr. Pascal Spothelfer – President & CEO, Genome BC
Dr. Gavin Stuart – Vice Provost Health, Faculty of Medicine, University of British Columbia
Dr. James Taylor – CEO, Precision Nanosystems Inc.
Dr. Paul Terry – President & CEO, PHEMI Health Systems
Observers to the Board
Joseph Garcia – Partner, Blake, Cassels & Graydon LLP
Hector MacKay-Dunn, J.D. Q.C. – Senior Partner, Farris, Vaughan, Wills & Murphy LLP